CTRI/2015/10/006235已完成未知
ROLE OF ANTITUBERCULAR TREATMENT FOR POSITIVE ENDOMETRIAL ASPIRATE DNA-PCR ON REPRODUCTIVE OUTCOME IN INFERTILE PATIENTS IN INDIAN SETTING-A RANDOMISED TRIA
ICMR0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •The inclusion criteria included women who were in the reproductive age group (20-40 years) with primary or secondary infertility and cohabiting with their husbands. Patients with positive endometrial DNA-PCR, with patent tubes on laparoscopy and all other tests (EA-HPE, AFB, Laparoscopy) being negative for genital TB were included in the study. Patients above the age of 40 years with symptoms suggestive of genital TB except infertility and HSG suspicious of genital TB due to extravasation or calcification or genital TB diagnosed on basis of EA-histopathology, AFB smear, hysteroscopy and laparoscopic findings were excluded from the study. Patients were randomized by block randomization into two groups: Group I where patients received ATT for 6 months was given and Group II where patients were not given ATT. A total of 100 infertile women (50 in each group), as per inclusion/exclusion criteria were recruited.
排除标准
- •−Age >40 years
- •−Symptoms suggestive of Genital TB except infertility
- •−HSG suspicious of genital TB due to extravasation or calcification
- •−Genital TB diagnosed on basis of EA-histopathology, AFB smear, Bactec culture, hysteroscopy and laparoscopic findings
研究者
相似试验
尚未招募
Unknown
To compare number of healthy household contacts aged between 6 to 18 years developing TB disease with tor without TB prophylactic therapy.CTRI/2023/04/052146Dr Poulomi Roy
已完成
不适用
Mycobacteria infection in incomplete transverse myelitisIncomplete transverse myelitis (ITM)Nervous System DiseasesEncephalitis, myelitis and encephalomyelitisISRCTN57081310Sun Yat-sen University (China)67
招募中
不适用
Tuberculosis (TB) Aftermath: a trial to find recurrent TB among people who have had TB previouslyCTRI/2020/05/025059ational Institutes Of Health NIH USA
招募中
2 期
The tuberculosis treatments by anti-tuberculosis dry powder prepared as nano-particulate system for inhaling into the respiratory systempatient with pulmonary tuberculosispulmonary tuberculosis treatment,dry powder inhalerTCTR20190404002Government Pharmaceutical Organization (GPO)208
进行中(未招募)
4 期
Anti-TB therapy following drug-induced liver injury (TB-DILI)Drug induced liver injury in patients receiving tuberculosis treatment.RespiratoryISRCTN92067975ottingham Clinical Trials Unit350
